MRLN fell -16.74% in Friday's regular session to $3.68, down from Wednesday's close of $4.42. The drop follows Q2 2026 results reported after Wednesday's close: revenue of about $2.2 million missed the roughly $3.8 million consensus, and an adjusted loss of $1.11 per share was far wider than the $0.28 expected.

YSS is down -11.03% to $10.24 in early regular trading on Aug. 14, versus a prior close of $11.51. The decline extends a post-earnings selloff that began after the Aug. 13 close and steepened in premarket trading, where shares fell roughly -15% at the lows.

HAWK is down -1.58% in premarket trading on Aug 13, slipping to about $24.34 from a $24.73 prior close. The move follows a -1.43% regular-session decline on Aug 12 and comes ahead of Q2 results due after today's close.

BETA Technologies shares surged approximately 41% over the past 30 days, propelled by an eight-day winning streak that added roughly $1.6 billion in market capitalization. The rally was ignited by a landmark announcement that the U.S. Export-Import Bank intends to expand its financing relationship with BETA to up to $1 billion, providing non-dilutive growth capital for manufacturing expansion.

Arxis (ARXS) surged approximately 37.6% over the past 30 days, rallying from $41.79 on July 10 to $57.51 by August 10, driven by a blockbuster second-quarter earnings report. The company reported Q2 2026 revenue of $501 million, up 25% year-over-year, and adjusted EPS of $0.28, soundly beating consensus estimates that had called for a loss of $0.07 per share.

Record quarterly revenue of $234.07 million, up 62% year-over-year, narrowly surpassing consensus estimates of approximately $231.6 million. GAAP loss per share of $0.08 missed the consensus estimate of a $0.06 loss, driven in part by acquisition-related transaction costs.

AAR Corp. shares declined approximately 2.9% over the trailing 30 days, with the stock closing at $129.05 on July 24, 2026, down from $132.94 on June 24. The company reported record Q4 FY2026 results on July 21, with sales of $928 million and adjusted EPS of $1.53, both exceeding Wall Street consensus estimates.

Revenue expectations: Wall Street consensus points to approximately $231.6 million in Q2 revenue, representing roughly 60% year-over-year growth from $144.5 million a year ago. Earnings forecast: Analysts project a GAAP loss of approximately $0.06 per share, narrowing from a loss of $0.13 per share in Q2 2025.

Revenue reached $2.55 billion , up 24% year-over-year and well above the consensus estimate of approximately $2.43 billion. Adjusted earnings per share (EPS) of $1.33 surpassed analyst expectations of $1.24, marking a 46% increase from $0.91 in the same quarter last year.

RTX shares have gained approximately 4.3% over the past 30 days, reflecting steady investor confidence driven by new defense contracts and European production expansion. Raytheon secured a $1.1 billion U.S. Navy contract for AIM-9X Block II missiles in late June and announced plans to double Stinger missile output through European partnerships.

SPCX plunged -10.28% during Wednesday's regular session, falling to $112.44 from Tuesday's close of $125.33, as investors reacted to the company's first-ever quarterly earnings as a public company. The sell-off was driven by SpaceX's Q2 results released after Tuesday's close: despite a revenue beat ($78B vs. $68.1B consensus), operating metrics disappointed — only 38 rocket launches versus 43 expected and payload mass well below Street estimates.

FTAI Aviation shares have pulled back roughly 9% over the past 30 days, retreating from approximately $248 to the $225 area, following a second-quarter earnings report that missed consensus EPS estimates despite record quarterly revenue. The company reported Q2 2026 revenue of $953 million, up 40.9% year-over-year, while adjusted EPS of $1.13 came in below the $1.32 analyst consensus, triggering post-earnings selling pressure.

Rocket Lab Corporation (RKLB) closed at $70.43 on August 3, 2026, down approximately 53% from its May 2026 all-time high of $151.00, meaning the stock would need to more than double to reclaim the $150 level. The strongest bullish case rests on a record $2.2 billion backlog, accelerating revenue growth above 60% year-over-year, the upcoming Neutron medium-lift rocket, and the transformative $8 billion acquisition of IRDM (Iridium Communications).

SpaceX (SPCX) shares have declined approximately 34% over the past 30 days, falling from $162.00 on July 2 to around $106.33 as of early August, and are now trading well below the June IPO price of $135. The stock's all-time high of $225.64, reached on June 16, has given way to a sustained sell-off that has erased over $1 trillion in market capitalization from peak levels.

Space Exploration Technologies Corp. (SPCX) closed at $108.37 on July 31, 2026, roughly 28% below the $150 level that marked its Nasdaq opening trade on June 12. The stock has fallen approximately 52% from its all-time high of $225.64 and now trades about 20% below its IPO price of $135.

Price target in focus: $300 per share, representing roughly 45% upside from the latest close near $207 and aligning with RBC Capital's Street-high analyst target. Strongest bullish factors: A "develop once, deploy everywhere" business model that sustains industry-leading margins, a defense and space segment contributing approximately 41% of revenue, and the potential for spinoff-related value unlocking as an independent pure-play aerospace company.

LHX shares tumbled -8.31% during Thursday's regular session to $272.81, extending a post-earnings selloff that began after the company reported Q2 2026 results following Wednesday's close. The decline comes despite strong Q2 results: revenue rose +8% to $5.9 billion, GAAP EPS of $3.13 beat consensus by nearly +12%, and full-year revenue and EPS guidance were both raised.

Planet Labs PBC (PL) shares have fallen approximately 38% over the last 30 days, dropping from $31.28 on June 29 to roughly $19.47 as of July 29, 2026. The stock's decline was driven by a combination of dilution fears tied to a $1.5 billion at-the-market equity offering, post-SpaceX IPO capital rotation, and multiple insider stock sales throughout July.

Revenue beat expectations: Boeing reported Q2 revenue of $24.6 billion, exceeding the Bloomberg consensus estimate of $24.26 billion and rising 8% year-over-year. Loss wider than anticipated: Core (non-GAAP) loss per share came in at $0.76, well above the $0.28 consensus loss estimate, driven by ongoing profitability challenges.

Boeing is scheduled to report Q2 2026 results on Tuesday, July 28, before the market opens, with a conference call at 10:30 a.m. ET. Wall Street consensus estimates point to a loss of approximately $0.27 to $0.28 per share, a sharp improvement from the $1.24 loss reported in Q2 2025.